Delivery Order SPE2DB22D1106-SPE2DB25FEFS2

Award Date 4/1/25
Potential Completion Date 4/2/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the purchase of PEDVAXHIB vaccine vials. The contract has a ceiling value of $1,004.81 and a final completion date of February 21, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of PEDVAXHIB vaccine vials. The ceiling value of the contract is $3,275.30, with a period of performance running through February 11, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This appears to be a task order issued under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML, with a ceiling value of $5,557.80 and a period of performance through December 17, 2024. The contract is a Firm Fixed Price arrangement, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,817.10 firm-fixed-price delivery order is for the supply of PEDVAXHIB vaccine vials. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of the PEDVAXHIB vaccine vial 0.5ML to the Defense Logistics Agency (DLA). The $1,718.45 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of July 27, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award, valued at $1,752.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PEDVAXHIB vaccine vials, with an ultimate completion date of September 18, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The award is for the provision of PEDVAXHIB vaccine vials (0.5 ml) with a ceiling value of $4,021.82 and a performance period through April 9, 2024. This delivery order is placed under an existing indefinite delivery contract (IDC) awarded solely to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the PEDVAXHIB vaccine vial (0.5 mL) to the U.S. government. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $2,014.68 and a completion date of July 11, 2024. This is a Firm Fixed Price Delivery Order contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract...
This federal contract award, worth $5,687.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEDVAXHIB vaccine vials (0.5ML) and has a completion date of February 6, 2025. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of PEDVAXHIB 0.5ML 10S medical products. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a ceiling value of $17,996.45. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of January 24, 2025. This award is part of a larger Indefinite...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEFS2
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of PEDVAXHIB vaccine vials. The contract has a ceiling value of $1,301.65 and a period of performance through April 2, 2025. It is a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, and the contract award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that the company holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally.

Generated 7/1/25, 10:28 AM